Literature DB >> 27746979

Reconsidering lung cancer screening: is biannual screening possible?

Alberto Ruano-Ravina1, Alberto Fernandez-Villar2, Mariano Provencio-Pulla3.   

Abstract

Entities:  

Year:  2016        PMID： 27746979      PMCID： PMC5059356          DOI： 10.21037/jtd.2016.09.30

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN： 2072-1439            Impact factor:   2.895


× No keyword cloud information.
  18 in total

1.  Radiation risks in lung cancer screening programs: a comparison with nuclear industry workers and atomic bomb survivors.

Authors:  Robert J McCunney; Jessica Li
Journal:  Chest       Date:  2014-03-01       Impact factor: 9.410

2.  Lung cancer CT screening: is annual screening necessary?

Authors:  John K Field; Stephen W Duffy
Journal:  Lancet Oncol       Date:  2016-03-18       Impact factor: 41.316

3.  Cost-effectiveness of CT screening in the National Lung Screening Trial.

Authors:  William C Black; Ilana F Gareen; Samir S Soneji; JoRean D Sicks; Emmett B Keeler; Denise R Aberle; Arash Naeim; Timothy R Church; Gerard A Silvestri; Jeremy Gorelick; Constantine Gatsonis
Journal:  N Engl J Med       Date:  2014-11-06       Impact factor: 91.245

Review 4.  Screening for lung cancer: time for large-scale screening by chest computed tomography.

Authors:  Dekel Shlomi; Ronny Ben-Avi; Gingy Ronen Balmor; Amir Onn; Nir Peled
Journal:  Eur Respir J       Date:  2014-02-13       Impact factor: 16.671

5.  Targeting of low-dose CT screening according to the risk of lung-cancer death.

Authors:  Anil K Chaturvedi; Hormuzd A Katki; Stephanie A Kovalchik; Martin Tammemagi; Christine D Berg; Neil E Caporaso; Tom L Riley; Mary Korch; Gerard A Silvestri
Journal:  N Engl J Med       Date:  2013-07-18       Impact factor: 91.245

6.  Detection of lung cancer through low-dose CT screening (NELSON): a prespecified analysis of screening test performance and interval cancers.

Authors:  Nanda Horeweg; Ernst Th Scholten; Pim A de Jong; Carlijn M van der Aalst; Carla Weenink; Jan-Willem J Lammers; Kristiaan Nackaerts; Rozemarijn Vliegenthart; Kevin ten Haaf; Uraujh A Yousaf-Khan; Marjolein A Heuvelmans; Erik Thunnissen; Matthijs Oudkerk; Willem Mali; Harry J de Koning
Journal:  Lancet Oncol       Date:  2014-10-01       Impact factor: 41.316

7.  Lung cancer probability in patients with CT-detected pulmonary nodules: a prespecified analysis of data from the NELSON trial of low-dose CT screening.

Authors:  Nanda Horeweg; Joost van Rosmalen; Marjolein A Heuvelmans; Carlijn M van der Aalst; Rozemarijn Vliegenthart; Ernst Th Scholten; Kevin ten Haaf; Kristiaan Nackaerts; Jan-Willem J Lammers; Carla Weenink; Harry J Groen; Peter van Ooijen; Pim A de Jong; Geertruida H de Bock; Willem Mali; Harry J de Koning; Matthijs Oudkerk
Journal:  Lancet Oncol       Date:  2014-10-01       Impact factor: 41.316

8.  The National Lung Screening Trial: results stratified by demographics, smoking history, and lung cancer histology.

Authors:  Paul F Pinsky; Timothy R Church; Grant Izmirlian; Barnett S Kramer
Journal:  Cancer       Date:  2013-08-26       Impact factor: 6.860

9.  Screening for lung cancer: U.S. Preventive Services Task Force recommendation statement.

Authors:  Virginia A Moyer
Journal:  Ann Intern Med       Date:  2014-03-04       Impact factor: 25.391

10.  Lung cancer incidence and mortality in National Lung Screening Trial participants who underwent low-dose CT prevalence screening: a retrospective cohort analysis of a randomised, multicentre, diagnostic screening trial.

Authors:  Edward F Patz; Erin Greco; Constantine Gatsonis; Paul Pinsky; Barnett S Kramer; Denise R Aberle
Journal:  Lancet Oncol       Date:  2016-03-18       Impact factor: 41.316
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.